Virios Therapeutics

/Virios Therapeutics

IPO

Virios Therapeutics

Biotechnology

We are a development-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (“FM”).

Symbol

VIRI

Price Range
$9.00 - $11.00

Final Shares
3,000,000

Anticipated Date
December 17, 2020

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Virios Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277